scout
|Videos|April 18, 2022

Venetoclax for Multiple Myeloma: The Phase 3 BELLINI Trial

Sponsored in Part by AbbVie/Content Independently Developed by Targeted Oncology. Dr. Shaji Kumar reviews data from his BELLINI clinical trial studying venetoclax paired with bortezomib and dexamethasone for multiple myeloma treatment.

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME